Thomas Jefferson University has added Bo Lu, MD, PhD, Professor of Radiation Oncology, and Nicole Simone, MD, Assistant Professor of Radiation Oncology to its Department of Radiation Oncology. Dr. Lu comes from Vanderbilt University, where he was Director of the Translational Research Program and Lung Cancer Research Program, focusing on radiation-induced cell death in lung patients. At Jefferson he will also serve as Director for the Molecular Radiation Biology Division.
Dr. Simone, who was previously at the NCI, specializes in breast and head and neck cancers, and her research involves radiation's effect on microRNAs and caloric restriction and radiation therapy.
North Shore-LIJ Health System has announced the appointment of Thomas McGinn, MD, as Chair of Medicine at North Shore University Hospital (NSUH) and LIJ Medical Center, and Professor of Medicine and Chairman of the Department of Medicine at Hofstra North Shore-LIJ School of Medicine. Dr. McGinn, an authority on evidence-based medicine, comparative effectiveness, and medical education, comes from Mount Sinai Medical Center, where he was Chief of General Internal Medicine. He will oversee all medicine programs at NSUH and LIJ Medical Center, including 145 full-time faculty physicians and approximately 1,500 voluntary physicians, as well as approximately 140 medical residents of the Department of Medical Graduate Education.
The American Society for Blood and Marrow Transplantation has honored Richard Champlin, MD, the founding president of the ASBMT, with its Lifetime Achievement Award. The award recognizes Dr. Champlin, head of the University of Texas MD Anderson Cancer Center Department of Stem Cell Transplantation and Cellular Biology, for his career-long work developing and improving blood stem cell transplantation as cancer therapy.
Leslie Wexner and Limited Brands Foundation have announced a $100 million philanthropic commitment to Ohio State University, which includes $65 million from Wexner, and $35 million from Limited Brands Foundation. The gift will primarily benefit The Ohio State University Medical Center and The Arthur G. James Cancer Hospital and Richard J. Solove Research Institute. It will also benefit Ohio State's Wexner Center for the Arts and select other university initiatives. With the announcement, the Wexner family and Limited Brands Foundation have given, raised, or pledged nearly $200 million to Ohio State, with the Wexner family's prior contributions to the university exceeding $35 million. Wexner is a 1959 graduate of Ohio State.
Mohammad Jahanzeb, MD, has joined Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine. Dr. Jahanzeb serves as Medical Director of the Deerfield Beach facility of Sylvester. He is also Professor of Medicine in the Division of Hematology/Oncology and Associate Director for Community Outreach. Dr. Jahanzeb comes to Sylvester following several years of private practice in Boca Raton with Aptium Oncology, and was previously an endowed professor at the University of Tennessee Health Science Center.
Celine Mascaux, MD, PhD, a postdoctoral fellow at the University of Colorado Cancer Center, has been named a winner of the National Lung Cancer Partnership Young Investigator Grant. Dr. Mascaux, 36, is one of six young researchers worldwide to receive the award. Her research has identified molecular changes in patients with early-stage lung cancer that distinguish the presence of lesions in patients at low risk from those at high risk or who already have invasive cancer.
A University of Texas MD Anderson Cancer Center research team has been chosen for the 2010 Cozzarelli Prize in the Biological Science category for their paper in Proceedings of the National Academy of the Sciences last year that described how the nuclear protein ataxia-telangiectasia mutated (ATM) plays a role in controlling and killing damaged cells in the area between the nucleus and the cell membrane.
The team was lead by Cheryl Walker, PhD, Professor in the Department of Molecular Carcinogenesis. Co-first author is Angela Alexander, a doctoral student at the University of Texas Graduate School of Biomedical Sciences, operated jointly by MD Anderson and the University of Texas Health Science Center at Houston. The initial discovery was made by postdoctoral fellow Shengli Cai, PhD. The award will be presented during the National Academy of Sciences Annual Meeting in May.
Rose Mary Carroll-Johnson, RN, MN, oncology nurse, researcher, author, and editor of Oncology Nursing Forum for more than 20 years, died on February 21, from cancer. She was an active member of the Oncology Nursing Society, serving on the Society's first Steering Council in 1996. She coedited two editions of the popular Psychosocial Nursing Care Along the Cancer Continuum along with Linda M. Gorman and Nancy Jo Bush.
Ms. Carroll-Johnson was employed as a senior research specialist in Nursing Research and Education at the City of Hope Medical Center and previously worked at UCLA School of Nursing among other organizations. She had also served as editor of the Journal of Hospice and Palliative Nursing, Nursing Diagnosis, and the International Journal of Nursing Terminologies and Classifications.
Last year ONS renamed an award in her honor, the Rose Mary Carroll-Johnson ONS Distinguished Award for Consistent Contribution to Nursing Literature, given to recognize individuals who have made consistent and significant contributions to the oncology nursing literature.
A team at Fred Hutchinson Cancer Research Center/University of Washington will receive the American Association for Cancer Research's Fifth Annual Team Science Award, which will be presented at the Annual Meeting next month in Orlando. The Fred Hutchinson team has worked on human papillomavirus (HPV) for more than 20 years, and the award recognizes an outstanding interdisciplinary research team for innovative and meritorious science that has advanced or will likely advance cancer research, detection, diagnosis, prevention, or treatment.
The 12-member team, led by Denise Galloway, PhD (left), head of the Cancer Biology Program, showed that HPVs are associated with nearly all genital-tract cancers and with a significant proportion of head and neck cancers, and that exposures, including a high number of sexual partners and early age at first intercourse, were common across most of the anogenital cancer sites.
The researchers also identified factors beyond sexual activity, such as immunosuppression, that contributed to HPV infection. Additionally, the team developed and tested new strategies for early detection and treatment of HPV-related cancers.
The AACR Team Science Award is supported by a grant from Eli Lilly and Company, and the team will collectively receive $50,000.
The other members of the winning team are:
© 2011 Lippincott Williams & Wilkins, Inc.
- Janet Daling, PhD, Member Emeritus, Public Health Sciences Division, and Professor Emeritus in the Department of Epidemiology.
- James Hughes, PhD, Professor, Department of Biostatistics.
- Nancy Kiviat, MD, Professor, Department of Pathology.
- Laura Koutsky, PhD, Professor, Department of Epidemiology.
- Margaret Madeleine, PhD, Assistant Member, Public Health Sciences Division and Assistant Professor, Department of Epidemiology.
- Constance Mao, MD, Assistant Professor, Department of Obstetrics and Gynecology and Director, Harborview Women's Colposcopy Clinic;
- Barbara McKnight, PhD, Member, Public Health Sciences Division, and Professor, Department of Biostatistics, University of Washington.
- Peggy Porter, MD, Member, Human Biology and Public Health Sciences Divisions, and Professor, Department of Pathology, University of Washington.
- Stephen Schwartz, PhD, Member, Public Health Sciences Division, and Professor, Department of Epidemiology.
- Hisham Tamimi, MD, Professor, Department of Obstetrics and Gynecology.
- Long-fu Xi, PhD, Research Associate Professor, Department of Pathology.
More on ONCOLOGY-TIMES.com...